In the murine MM model, a CSF1R inhibitor demonstrates a therapeutic effect against cancer by repolarizing MAMs to adopt an M1-like phenotype and inducing a cytotoxic CD4+ T-cell response against tumor cells213. Here, CSF1R is linked to Miyoshi myopathy.